Simeprevir plus sofosbuvir for eight or 12 weeks in treatment-naïve and treatment-experienced hepatitis C virus genotype 4 patients with or without cirrhosis.

Saved in:
Bibliographic Details
Title: Simeprevir plus sofosbuvir for eight or 12 weeks in treatment-naïve and treatment-experienced hepatitis C virus genotype 4 patients with or without cirrhosis.
Authors: El Raziky, M.1 maelraziky@yahoo.com, Gamil, M.2, Ashour, M. K.1, Sameea, E. A.3, Doss, W.4, Hamada, Y.1, Van Dooren, G.2, DeMasi, R.5, Keim, S.6, Lonjon‐Domanec, I.7, Hammad, R.4, Hashim, M. S.3, Hassany, M.4, Waked, I.3
Source: Journal of Viral Hepatitis. Feb2017, Vol. 24 Issue 2, p102-110. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13520504
DOI:10.1111/jvh.12625